iifl-logo

Kilitch Drugs (India) Ltd Share Price

357
(1.96%)
Apr 24, 2025|09:58:53 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open352.8
  • Day's High368
  • 52 Wk High404.95
  • Prev. Close350.15
  • Day's Low351.6
  • 52 Wk Low 299.95
  • Turnover (lac)35.17
  • P/E23.93
  • Face Value10
  • Book Value150.92
  • EPS14.57
  • Mkt. Cap (Cr.)574.14
  • Div. Yield0
View All Historical Data
No Records Found

Kilitch Drugs (India) Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

352.8

Prev. Close

350.15

Turnover(Lac.)

35.17

Day's High

368

Day's Low

351.6

52 Week's High

404.95

52 Week's Low

299.95

Book Value

150.92

Face Value

10

Mkt Cap (₹ Cr.)

574.14

P/E

23.93

EPS

14.57

Divi. Yield

0

Kilitch Drugs (India) Ltd Corporate Action

26 Aug 2024

12:00 AM

BookCloser

arrow

26 Aug 2024

12:00 AM

AGM

Announcement Date: 26 Aug, 2024

arrow

3 Feb 2025

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

Kilitch Drugs (India) Ltd NEWS AND UPDATE

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Kilitch Drugs (India) Ltd SHAREHOLDING SNAPSHOT

24 Apr, 2025|10:21 AM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 69.23%

Foreign: 0.00%

Indian: 69.23%

Non-Promoter- 0.00%

Institutions: 0.00%

Non-Institutions: 30.76%

Custodian: 0.00%

Share Price

Kilitch Drugs (India) Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Y/e 31 Mar( In .Cr)Mar-2024Mar-2023Mar-2022Mar-2021

Equity Capital

16.08

20.58

18.08

15.49

Preference Capital

0

0

0

0

Reserves

206.84

175.35

159.95

147.44

Net Worth

222.92

195.93

178.03

162.93

Minority Interest

View Balance Sheet
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2019Mar-2018

Revenue

70.01

60.76

96.41

50.45

yoy growth (%)

15.21

-36.97

91.08

79.31

Raw materials

-39.06

-35.75

-52.98

-25.9

As % of sales

55.79

58.83

54.95

51.34

Employee costs

-5.21

-5.65

-5.22

-4.21

View Profit & Loss
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2019Mar-2018

Profit before tax

7.5

5.22

19.52

7.15

Depreciation

-1.14

-1.15

-1.2

-1.19

Tax paid

-1.35

-0.76

-4.75

-0.96

Working capital

-1.1

-5.99

6.43

6.49

Other operating items

View Cash Flow
Y/e 31 MarMar-2021Mar-2020Mar-2019Mar-2018

Growth matrix (%)

Revenue growth

15.21

-36.97

91.08

79.31

Op profit growth

276.91

-91.66

197.85

-2,095.55

EBIT growth

39.14

-70.16

178.12

-1,655.73

Net profit growth

38.1

-69.81

138.33

-17,121.7

View Ratios
Particulars (Rupees in Crores.)Mar-2024Mar-2023Mar-2022Mar-2021Mar-2020

Gross Sales

154.37

139.6

114.23

68.52

53.32

Excise Duty

0

0

0

0

0

Net Sales

154.37

139.6

114.23

68.52

53.32

Other Operating Income

0

0

0

0

0

Other Income

4.48

2.92

2.91

2.67

4.13

Kilitch Drugs (India) Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceutical Industries Ltd

SUNPHARMA

1,788.8

136.254,29,217.031,181.050.755,985.3398.33

Divis Laboratories Ltd

DIVISLAB

5,924.5

75.781,57,100.325940.512,297513.62

Cipla Ltd

CIPLA

1,533.7

26.611,23,852.121,438.150.854,134.87360.73

Torrent Pharmaceuticals Ltd

TORNTPHARM

3,332.4

61.861,12,844.494850.842,330222.38

Mankind Pharma Ltd

MANKIND

2,545.5

54.31,05,003.3416.3802,396.57334.17

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Kilitch Drugs (India) Ltd

Management

Register Office

Registrar Office

Chairman & Managing Director

Mukund P Mehta

Whole-time Director

Bhavin M Mehta

Independent Director

Hemang Engineer

Managing Director

Mira Bhavin Mehta

Independent Director

Murti Vasudev Krishna

Independent Director

Venkita Subramanian Rajan

Company Sec. & Compli. Officer

Pushpa Nyoupane

Independent Director

Dipen Jayantilal Jain

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Summary

Kilitch Drugs (India) Limited (KDIL), incorporated in May, 1992 is the one of the leading and fastest growing pharmaceutical companies in the world, manufacturing, supplying and marketing broad range of pharmaceutical formulations in the various dosage forms like Solid, Liquid and Parental across the globe. Their extensive research efforts have led to development of comprehensive, diverse and highly complementary portfolio of medicines targeting a wide spectrum of chronic and acute treatments which includes Sterile dosages namely Injectables & Ophthalmic, Effervescent tablets & Granules, Tablets & Capsules, OTC range covering varied Nutraceuticals & Cosmetics and Medical devices.The Company is engaged in development, manufacturing and marketing of quality finished dosages. The Company is one of the most reliable manufacturer of injectables in India and one of the largest manufacturer of cephalosporins in Africa having its manufacturing unit located in India and Ethiopia. Its services range from manufacturing to marketing a host of formulations in all dosage forms i.e. solid, liquid and parenteral forms of creating safe pharmaceutical solutions.The Company went public in Feb.94 to set up a pharmaceutical formulation plant at Thane to manufacture pharmaceutical products in the form of tablets, capsules,liquid orals, ointments, creams and injectables. Even before the plant was commissioned, the company came out with a rights issue in Oct.95 to expand the injectible capacity. Com
Read More

Company FAQs

What is the Kilitch Drugs India Ltd share price today?

The Kilitch Drugs India Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is ₹357 today.

What is the Market Cap of Kilitch Drugs India Ltd?

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Kilitch Drugs India Ltd is ₹574.14 Cr. as of 24 Apr ‘25

What is the PE and PB ratio of Kilitch Drugs India Ltd?

The PE and PB ratios of Kilitch Drugs India Ltd is 23.93 and 2.37 as of 24 Apr ‘25

What is the 52 Week High and Low of Kilitch Drugs India Ltd?

The 52-week high/low is the highest and lowest price at which a Kilitch Drugs India Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Kilitch Drugs India Ltd is ₹299.95 and ₹404.95 as of 24 Apr ‘25

What is the CAGR of Kilitch Drugs India Ltd?

Kilitch Drugs India Ltd's CAGR for 5 Years at 27.67%, 3 Years at 21.71%, 1 Year at -0.36%, 6 Month at 12.21%, 3 Month at 6.01% and 1 Month at -3.37%.

What is the shareholding pattern of Kilitch Drugs India Ltd?

The shareholding pattern of Kilitch Drugs India Ltd is as follows:
Promoters - 69.23 %
Institutions - 0.00 %
Public - 30.77 %

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.